New Study Evaluates Use of the Nerivio® REN Wearable for Treatment of Migraine in Children Under the Age of 12
Nerivio, currently indicated for use in ages 12 and older, demonstrates study results in younger children with migraine. BRIDGEWATER, N.J. and NETANYA, Israel, July 25, 2024 /PRNewswire/ -- Theranica, a neuromodulation therapeutics company, today …